Rituximab in the Treatment of Idiopathic Membranous Nephropathy

Clinical Trial ID NCT00405340

PubWeight™ 2.68‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00405340

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol 2010 1.89
2 Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study. Nephrol Dial Transplant 2012 0.86
Next 100